NCT06780995

Brief Summary

Weakness is one of the most common consequences of stroke. For the over 750,000 Canadians living with stroke, many daily activities like standing from a chair, walking and balance not only require strength but often efforts in bursts, known as muscle power. Strength training can improve muscle strength and, when performed at higher speeds, can help build muscle power. Current guidelines for stroke recommend strength training but these are commonly performed at lower intensities and do not include any focus on building muscle power. There has been very little research on power training after stroke. A 10-week power training program for people living with stroke, Power Exercise for Stroke Recovery (POWER-Feasibility, NCT05816811) was recently evaluated. POWER includes 3 phases of progressive exercise: building familiarity with the upper and lower body exercises, then strength, and lastly muscle power. The results from POWER-Feasibility are promising, suggesting that POWER is safe and may improve stroke recovery. POWER-Feasibility was a small study (15 participants), and POWER was not compared to a control intervention. A pilot randomized controlled trial of POWER (POWER-Pilot) will now be conducted. Sixty people who are at least 6 months after stroke will be recruited. They will be randomly assigned to participate in POWER or standard strength training for stroke at lower intensities and without focus on power training. The feasibility of a randomized study will be examined, and whether POWER can improve walking, strength and balance compared to the control group. Results from POWER-Pilot will help design a larger randomized trial in the future (POWER-RCT), and may ultimately be important for stroke rehabilitation teams to better understand whether power training can help people recovering from stroke.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P50-P75 for not_applicable stroke

Timeline
17mo left

Started Sep 2025

Typical duration for not_applicable stroke

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress34%
Sep 2025Sep 2027

First Submitted

Initial submission to the registry

December 9, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 17, 2025

Completed
8 months until next milestone

Study Start

First participant enrolled

September 15, 2025

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2027

Expected
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2027

Last Updated

December 23, 2025

Status Verified

December 1, 2025

Enrollment Period

1.5 years

First QC Date

December 9, 2024

Last Update Submit

December 16, 2025

Conditions

Keywords

StrokeAgingResistance trainingPower trainingPhysical functionCommunity exerciseQuality of lifeRehabilitation

Outcome Measures

Primary Outcomes (12)

  • Feasibility: Randomization - Percentage of participants allocated as assigned

    Indicator: Yes/No; Criteria for success and progression: Success: 100% participants allocated as assigned, Revise: \<100% participants allocated as assigned

    Through study completion, over 24 months

  • Feasibility: Randomization - Clinically important difference between groups

    Indicator: Balance of prognosis; Criteria for success and progression: Success: No clinically important differences between groups, Revise: Clinically important differences between groups

    Through study completion, over 24 months

  • Feasibility: Allocation concealment

    Indicator: Yes/No; Criteria for success and progression: Success: Allocation concealment preserved, Revise: Allocation revealed

    Through study completion, over 24 months

  • Feasibility: Assessor blinding - Number of occurrences of unblinding

    Indicator: # occurrences of unblinding; Criteria for success and progression: Success: Assessors unblinded for \<5% of participants, Revise: Assessors unblinded for ≥5% of participants

    Through study completion, over 24 months

  • Feasibility: Contamination - Number of participants exposed to other intervention arm

    Indicator: # participants exposed to the other intervention arm; Criteria for success and progression: Success: No occurrences of contamination, Revise: Any occurrence of contamination

    Through study completion, over 24 months

  • Feasibility: Recruitment rate - Number of participants recruited per month

    Indicator: # recruited / month; Criteria for success and progression: Success: Mean 1.0 participants/month/site, Revise: Mean \<1.0 participants/month/site

    Through study completion, over 24 months

  • Feasibility: Retention rate - Percentage of participants with follow up data

    Indicator: % follow up data; Criteria for success and progression: Success: Complete follow up data in ≥80% participants, Revise: Complete follow up data in \<80% participants

    Through study completion, over 24 months

  • Feasibility: Participant and assessor burden - Percentage of participants completing study assessments in ≤1.5h

    Indicator: time to complete assessments; Criteria for success and progression: Success: ≥80% complete assessments in ≤1.5h, Revise: \<80% complete assessments in ≤1.5h

    Through study completion, over 24 months

  • Feasibility: Participant and assessor burden - Participant rating of the burden of assessments

    Indicator: perceived burden of assessments; Criteria for success and progression: Success: Rating ≤3 on 10-point Likert scale (1=not at all; 10=extremely burdensome), Revise: Rating \>3 out of 10

    Through study completion, over 24 months

  • Feasibility: Safety - Number of serious adverse events

    Indicator: Serious adverse events from assessments or interventions; Criteria for success and progression: Success: 0 occurrences, Revise: Any occurrences

    Through study completion, over 24 months

  • Feasibility: Treatment effect - Availability of clinical outcome data

    Indicator: Number of available data points at post-intervention; Criteria for success and progression: ≥90% (n=54/60) data available on all clinical outcomes of interest

    Through study completion, over 24 months

  • Functional mobility: Timed Up and Go (TUG) test (self- and fast-paced)

    The Timed Up and Go is a measure of functional mobility. A standard chair (\~46cm in height) will be placed at the start of a flat walking course and a cone will be placed 3 meters from the chair. Participants will stand from the chair, walk 3 meters, turn back towards the chair, and sit back down, without assistance. This will be completed at a comfortable pace and fast pace. The task will be timed and measured in seconds, a shorter time indicates better mobility and balance.

    Baseline (0 weeks), post-intervention (10 weeks), follow-up (18 weeks)

Secondary Outcomes (13)

  • Walking speed: 10-meter walking speed (self- and fast-paced)

    Baseline (0 weeks), post-intervention (10 weeks), follow-up (18 weeks)

  • Post-stroke fatigue: Fatigue Severity Scale-7 (FFS)

    Baseline (0 weeks), post-intervention (10 weeks), follow-up (18 weeks)

  • Psychological well-being: General Health Questionnaire-28

    Baseline (0 weeks), post-intervention (10 weeks), follow-up (18 weeks)

  • Cognition: Montreal Cognitive Assessment (MoCA)

    Baseline (0 weeks), post-intervention (10 weeks), follow-up (18 weeks)

  • Standing balance: Brief Balance Evaluation System Test (Brief BESTest)

    Baseline (0 weeks), post-intervention (10 weeks), follow-up (18 weeks)

  • +8 more secondary outcomes

Study Arms (2)

Power Exercise for Stroke Recovery (POWER)

EXPERIMENTAL

POWER involves 3 progressive phases: 1) Familiarization (1 week), 2) Strength (4 weeks, 2-3 sets, 5-8 repetitions), and 3) Power (5 weeks, 2-3 sets, 15-20 repetitions, fast tempo).

Other: Power Exercise for Stroke Recovery (POWER)

Strength Training Engaging Guidelines to Enhance Total Health (STRENGTH)

ACTIVE COMPARATOR

STRENGTH is based on current resistance exercise training (RET) clinical practice guidelines for stroke with no focus on power.

Other: Strength Training Engaging Guidelines to Enhance Total Health (STRENGTH)

Interventions

STRENGTH is based on current clinical practice guidelines for RET after stroke. It will include the same Familiarization week as the POWER program (Week 1), followed by progressive conventional RET involving 3 sets of 10-15 repetitions at moderate to high intensities (RPE 4-5 "Somewhat hard" to "Hard") (Weeks 2-10). The external resistance will be progressed to maintain this target RPE range. STRENGTH is matched with POWER in length (60-minute sessions over 10 weeks), frequency (3x/week) and format (in-person supervision).

Strength Training Engaging Guidelines to Enhance Total Health (STRENGTH)

POWER incorporates 3 progressive phases: Phase 1 Familiarization (Week 1) as a low-intensity version of the training program to acclimate participants to the movements (body weight resisted or light weights, RPE 2-3 "Fairly light" to "Moderate"). Phase 2 Strength (Weeks 2-5) progresses loads to achieve volitional fatigue within 6-8 repetitions (RPE 7-9 "Very hard" to "Very very hard"). Phase 3 Power (Weeks 6-10) will use intensities RPE 4-6 ("Somewhat hard" to "Very hard"), and exercises will be executed at the highest possible velocity to focus on muscle power. The Power phase is intentionally designed with exercises to emphasize functional movements such as fast sit to stands, lunging and calf raises.

Power Exercise for Stroke Recovery (POWER)

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ≥19 years old
  • ≥6 months poststroke,
  • able to walk \>10 meters with or without an assistive device
  • have mild to moderate stroke severity (modified Rankin Scale ≤3)
  • without significant cognitive impairment that would preclude safe exercise, screened via Montreal Cognitive Assessment-Blind score \<18

You may not qualify if:

  • Any contraindications to exercise for people with cardiovascular disease, such as unstable angina, uncontrolled hypertension, orthostatic blood pressure with exercise, or uncontrolled arrhythmias or
  • Actively engaged in or have made plans to engage in stroke rehabilitation services

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

The University of British Columbia - Okanagan Campus

Kelowna, British Columbia, V1V 1V7, Canada

RECRUITING

McMaster University

Hamilton, Ontario, L8S1C7, Canada

RECRUITING

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Central Study Contacts

Ada Tang, PT PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, Assistant Dean

Study Record Dates

First Submitted

December 9, 2024

First Posted

January 17, 2025

Study Start

September 15, 2025

Primary Completion (Estimated)

February 28, 2027

Study Completion (Estimated)

September 30, 2027

Last Updated

December 23, 2025

Record last verified: 2025-12

Locations